Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinaciclib in Relapsed/Refractory MCL or B-CLL
NCT00871546Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dinaciclib in mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), sponsored by Merck & Co.. Started Mar 2009; status: terminated.
02
Drugs
dinaciclib
03
Conditions
mantle cell lymphoma (MCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00871546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871546.